======= TMEM127 =======
== Gene Information ==
* **Official Symbol**: TMEM127
* **Official Name**: transmembrane protein 127
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55654|55654]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O75204|O75204]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TMEM127&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TMEM127|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613403|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a transmembrane protein with 3 predicted transmembrane domains. The protein is associated with a subpopulation of vesicular organelles corresponding to early endosomal structures, with the Golgi, and with lysosomes, and may participate in protein trafficking between these structures. Mutations in this gene and several other genes cause pheochromocytomas. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Aug 2010].
* **UniProt Summary**: Controls cell proliferation acting as a negative regulator of TOR signaling pathway mediated by mTORC1. May act as a tumor suppressor. {ECO:0000269|PubMed:20154675}.
No Pfam Domain information is available for this gene.
|negative regulation of TOR signaling|
|endosome organization|
|regulation of TOR signaling|
|Rab GTPase binding|
|early endosome|
|vesicle organization|
|endomembrane system organization|
|negative regulation of intracellular signal transduction|
|negative regulation of cell population proliferation|
|molecular function|
|negative regulation of signal transduction|
|negative regulation of cell communication|
|negative regulation of signaling|
|regulation of cell population proliferation|
|negative regulation of response to stimulus|
|regulation of intracellular signal transduction|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-2.92|
|[[:results:exp444|THZ531 0.225μM R08 exp444]]|-2.9|
|[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-2.68|
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-2.01|
|[[:results:exp531|THZ1 0.06μM R08 exp531]]|-1.86|
|[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-1.82|
|[[:results:exp534|Trientine 500μM R08 exp534]]|-1.78|
|[[:results:exp34|Rotenone 20μM R00 exp34]]|-1.77|
|[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.76|
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.77|
|[[:results:exp79|Q15 2.7μM R02 exp79]]|1.81|
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.29|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 3/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|1/15|
|prostate|0/1|
|skin|1/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7123
* **Expression level (log2 read counts)**: 5.76
{{:chemogenomics:nalm6 dist.png?nolink |}}